These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10285778)

  • 21. Refilling prescriptions and physician consent.
    Bobrt KF; Purohit AA
    Contemp Pharm Pract; 1982; 5(2):80-4. PubMed ID: 10256914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Food and Drug Administration, HHS. Final rule; delay of effective date; reopening of administrative record.
    Fed Regist; 2000 May; 65(86):25639-41. PubMed ID: 11010689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct-to-consumer advertising affects provider / patient relationship.
    Contracept Technol Update; 1998 Dec; 19(12):153-5. PubMed ID: 12321805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latinos' sources of medication and medication information in the United States and their home countries.
    Sleath B; Blalock SJ; Bender D; Murray M; Cerna A; Cohen MG
    Patient Educ Couns; 2009 May; 75(2):279-82. PubMed ID: 19046845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent).
    Kalsekar I; Sheehan C; Peak A
    Res Social Adm Pharm; 2007 Dec; 3(4):378-91. PubMed ID: 18082874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between pharmacy closures and prescription drug use: a retrospective analysis of Medicaid prescription claims in Iowa.
    Xiao H; Sorofman B; Manasse HR
    Am J Manag Care; 2000 Mar; 6(3):366-72. PubMed ID: 10977436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rx with a dose of info.
    Miller RW
    FDA Consum; 1980 Nov; 14(9):22-3. PubMed ID: 10309292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and evaluation of pharmacists' commonly used drug information sources.
    Wong PS; Ko Y; Sklar GE
    Ann Pharmacother; 2009 Feb; 43(2):347-52. PubMed ID: 19193588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seeking prescribing patterns in rural Crete: a pharmacoepidemiological study from a primary care area.
    Antonakis N; Xylouri I; Alexandrakis M; Cavoura C; Lionis C
    Rural Remote Health; 2006; 6(1):488. PubMed ID: 16464135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prescribing drugs to patients receiving out-patient care].
    Garjón Parra FJ
    An Sist Sanit Navar; 2009; 32(1):11-21. PubMed ID: 19430507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the use of an integrated drug information system by primary care physicians for vulnerable population.
    Kawasumi Y; Tamblyn R; Platt R; Ernst P; Abrahamowicz M; Taylor L
    Int J Med Inform; 2008 Feb; 77(2):98-106. PubMed ID: 17336141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which prescription for the illegible and unreadable DTC (direct-to-consumer) brief summary--major surgery or euthanasia?
    Hochhauser M
    Manag Care Q; 2002; 10(3):6-10. PubMed ID: 12476659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adolescents' preventive care experiences before entry into the State Children's Health Insurance Program (SCHIP).
    Shenkman E; Youngblade L; Nackashi J
    Pediatrics; 2003 Dec; 112(6 Pt 2):e533. PubMed ID: 14654675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. To market, to market. The nuts and bolts of prescription drug approval.
    Peterson AM
    Adv Nurse Pract; 2001 Apr; 9(4):87-90. PubMed ID: 12420443
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of factors associated with increased prescription illegibility: results from the National Ambulatory Medical Care Survey, 1990-1998.
    Gupta AK; Cooper EA; Feldman SR; Fleischer AB; Balkrishnan R
    Am J Manag Care; 2003 Aug; 9(8):548-52. PubMed ID: 12921232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HHS moves forward with E-prescribing standards.
    Flizar GM; Klein SR; Monson RA
    J Healthc Inf Manag; 2006; 20(3):10-2. PubMed ID: 16903653
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Language barriers to prescriptions for patients with limited English proficiency: a survey of pharmacies.
    Bradshaw M; Tomany-Korman S; Flores G
    Pediatrics; 2007 Aug; 120(2):e225-35. PubMed ID: 17671036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should expiration dates be required on patients' prescription labels?
    Hadeler F
    Am Pharm; 1986 Aug; NS26(8):30-5. PubMed ID: 3776829
    [No Abstract]   [Full Text] [Related]  

  • 40. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.